ORGANIZATION

• Japan Drug Wholesalers’ Workforce Down 3% for 2nd Year: JPWA Survey
  October 3, 2023

• Generic Use Rate Reaches Record 81.7% in April-June: JGA
  September 29, 2023

• Assess Evaluation Methods for Innovative Medical Products: Science Council
  September 28, 2023

• Ex-MHLW CMO Calls for Reasonable Pricing of Alzheimer’s Drugs
  September 27, 2023

• Shipments Restricted or Halted for 22.9% of Products in August: FPMAJ
  September 25, 2023

• JPMA Embarking on Creation of One-Stop Platform for Rare Disease Trial Info
  September 19, 2023

• Hiroyasu Kitagawa Named New Chief of Kyokai Kenpo
  September 19, 2023

• JPMA Optimistic on New Minister’s Commitment on Boosting Innovation: Exec
  September 15, 2023

• 4 Cell & Gene Therapies Represent 90% of Top 100 Bills in FY2022: Payer
  September 8, 2023

• Single-Wholesaler Model Has No Merits for Hospitals: Hyogo Doctors Group
  September 7, 2023

• Industry Calls for Clear Criteria for SaMD Reimbursement to Boost Predictability
  September 5, 2023

• HIV Groups Pin Hopes on MHLW’s Development Requests for Preventive Therapy
  September 4, 2023

• Only 1.2% of NSCLC Patients Receiving Gene Panel Tests: Survey
  September 1, 2023

• Shipments Restricted or Suspended for 22.4% of Products in July, No Sign of Improvement: FPMAJ
  August 31, 2023

• JPMA on Alert for IRA’s Drug Pricing Provisions, Boosting Cooperation with PhRMA
  August 29, 2023

• As 2040 Doctor Shortage Looms, Japan Consumer Healthcare Group Pushes Rx-to-OTC Switches for Hypertension Meds
  August 25, 2023

• Japan Citizens’ Group Objects to HPV Vaccination in Males
  August 25, 2023

• JPMA Taskforce Issues Proposal on Information Supply, Drug Development for Rare Diseases
  August 18, 2023

• Economic Burden of Preventable Cancer “Over 1 Trillion Yen”: NCC, NCGM
  August 17, 2023

• INES Proposes Extension of Public Funding for COVID Drugs
  August 7, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• …
• Next ›
• 最終 »